 |
 |

PNEUMONIA DUE TO TYPE I PNEUMOCOCCUSANALYSIS OF DEATHS IN CASES IN WHICH SERUM TREATMENT WAS USED
MILTON BENJAMIN ROSENBLÜTH, M.D.;
MORRIS BLOCK, M.D.
Arch Intern Med. 1936;58(1):102-116.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
It has been proved that specific serum definitely reduces the mortality in pneumonia due to type I pneumococcus. This fact has been amply demonstrated by several careful studies1 on large series of subjects, which, if taken together, total many thousands of patients treated with serum and a comparable number of controls. However, it is disconcerting that in the very reports which are submitted to prove the value of the treatment it is stated that a not inconsiderable number of patients treated with serum succumb in spite of its use. In the series studied by Park and his associates1a from the Bellevue, Harlem and New York hospitals, there was a mortality of 19 per cent in the cases in which serum treatment was used, and in the series reported by Cecil and Plummer1b there was a mortality of 20.1 per cent.
From 1929 to 1934 we have had
. . . [Full Text PDF of this Article]
Author Affiliations
Visiting Physician, Bellevue Hospital; Assistant Visiting Physician, Bellevue Hospital; NEW YORK
From the Department of Medicine, New York University College of Medicine, and the Medical Service of the Third (New York University) Medical Division, Bellevue Hospital.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|